image

Our commitment to a world free of malaria

image

Fosun Pharma at the 7th MIM Pan African Malaria Conference:
Welcome to our symposium.

At the Crossroad of Antimalarial Drug Resistance:
CHALLENGES AND SOLUTIONS

Learn more
image
image
image

Nearly half of the world’s population is at risk of malaria.

In 2016, an estimated 216 million cases of malaria occurred worldwide and there were an estimated 445,000 deaths from malaria globally.

Learn more
image

Fosun Pharma’s Innovative drug Artesun®

Artesun® (artesunate for injection), an innovative drug of Fosun Pharma, is fully IP-protected with guaranteed quality recommended by the WHO for severe malaria treatment. It has become the internationally recognized reference drug for treating severe malaria. The scale-up of effective tools in malaria prevention and control measures, including the adoption of injectable artesunate have led to a 18% reduction of the incidence rate of malaria between 2010-2016, with a continuous decrease of malaria mortality globally.

image

Innovation for Good Health

Staying true to its brand philosophy of “Innovation for Good Health”, Fosun Pharma has been relying on innovation to drive further growth. We commit to make efforts to provide better products and services to patients in the future, and work towards the great vision of building a “malaria-free world”.

Discovery more

2011—2017

100,000,000

Vials of injectable artesunate

Saved

20,000,000

Lives